[144] Upstart Holdings, Inc. Common stock SEC Filing
Rhea-AI Filing Summary
Upstart Holdings, Inc. (UPST) filing a Form 144 notifies a proposed sale of 365 common shares through Charles Schwab & Co., Inc. on 08/22/2025, with an aggregate market value reported as $25,551.00. The shares were acquired the same day via an employee stock option exercise and the transaction is described as a cashless exercise with broker payment.
The filing also lists five prior sales by the same person, totaling 13,317 shares sold between 05/23/2025 and 08/20/2025 for aggregate gross proceeds of $931,560.00. The filing includes the represenation that the seller has no undisclosed material adverse information.
Positive
- Disclosure completeness: The Form 144 provides required details including broker, acquisition method, share counts, and seller attestation.
- Transaction transparency: Acquisition method is specified as an employee stock option exercise and payment method as broker payment for cashless exercise.
Negative
- Insider sales volume: The filer sold 13,317 shares in the past three months for total gross proceeds of $931,560.00, indicating notable insider liquidity activity.
- Ongoing disposals: The proposed sale on 08/22/2025 continues recent sales activity, which some investors may view as increased insider selling pressure.
Insights
TL;DR: Routine insider sale following an employee option exercise; transaction appears administrative rather than strategic.
The Form 144 documents a small proposed sale of 365 shares tied to a same-day employee stock option exercise and cashless broker payment, which is a common mechanism for insiders to satisfy tax/option obligations. The filing provides transparent detail including broker, timing, and acquisition method. The recent three-month history shows larger dispositions totaling 13,317 shares for $931,560, which investors may consider when evaluating insider liquidity but not necessarily as evidence of company-specific negative information.
TL;DR: Filing meets Rule 144 disclosure requirements; contains explicit seller attestation about lack of undisclosed material information.
The document includes required Rule 144 elements: issuer and broker details, number of shares, acquisition date and method, and a seller attestation regarding material information. The listed cashless exercise and broker payment are properly noted. From a compliance perspective, the form is procedurally complete based on the provided fields; no regulatory exceptions or 10b5-1 plan adoption date is indicated in the filing text provided.